Risk of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Among Patients with Type 2 Diabetes Mellitus on Anti-Hyperglycemic Medications
Olawore et al., Clinical Epidemiology, doi:10.2147/CLEP.S458901
https://c19early.org/olawore.html